High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions

Patient response to P2Y12 inhibitor therapy is heterogeneous, and those with high on-treatment platelet reactivity (HTPR) are at an increased risk of thrombotic complications. The aim of our study was to determine whether selecting a high-risk patient group of individuals after complex percutaneous...

Descripción completa

Detalles Bibliográficos
Autores principales: Urban, Lukáš, Ingrid, Škorňová, Žolková, Jana, Ján, Staško, Bolek, Tomáš, Samoš, Matej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Manuscript
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498693/
https://www.ncbi.nlm.nih.gov/pubmed/37697705
http://dx.doi.org/10.1177/10760296231199089

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10498693/
https://www.ncbi.nlm.nih.gov/pubmed/37697705
http://dx.doi.org/10.1177/10760296231199089

Ejemplares similares